Huang Dennis Karl 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Oct 18, 2021
Insider Transaction Report
Form 4
Huang Dennis Karl
See Remarks
Transactions
- Sale
Common Stock
2021-10-14$81.14/sh−358$29,048→ 40,148 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.